Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q1 2022 Results - Earnings Call Transcript
Intellia Therapeutics, Inc. (NASDAQ:NASDAQ:NTLA) Q1 2022 Earnings Conference Call May 05, 2022, 08:00 ET Company Participants Ian Karp - SVP, IR & Corporate Communications John Leonard...
Source: seekingalpha.com